You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Selective Aortic Arch Perfusion Technologies for Hemorrhage-induced Cardiac Arrest

    SBC: Hays, Inc.            Topic: DHP16009

    Thereis increased interest in endovascular hemorrhagecontrol using aortic balloon occlusion to improve outcomes in preventable battlefield death from non-compressibletorso hemorrhage(NCTH). Our technology, the SABOT, is the nextgeneration in such catheters,which adds the ability of both selectivevascular bed perfusion, bypassinginjured beds, and partial perfusion. In phaseI thefeasibility and proo ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  2. Medical Electro-Textile Sensor Simulation

    SBC: LR TECHNOLOGIES, Inc.            Topic: DHP17A001

    In this topic, we plan to design a vital EMF sensor to work under any conditions. The sensor will be integrated with smart clothing and using e-textile materials.

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  3. Principled Design of an Augmented Reality Trainer for Medics

    SBC: UNVEIL LLC            Topic: DHP17A003

    Augmented reality (AR) offers the ability to enhance existing combat medic training by including perceptual cues and adaptive training elements to traditional simulation-based training using manikins. Unveil has developed a training system called the Macrocognitive AR Trainer (MART). MART is designed to foster the development of macrocognitive skills (e.g., sensemaking, assessment skills, mental m ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  4. Medical Device to Assess the Viability of Tissue Prior to Skin Grafting

    SBC: Spectral Md, Inc.            Topic: DHP17A006

    The primary objective of this Phase II proposal is to construct and validate the portable SpectralMD DeepView imaging technology designed previously in Phase I. This device allows surgeons to quickly and objectively assess tissue viability in burn surgery prior to skin grafting. DeepView uses machine learning and multispectral imaging to generate quantitative prognostic images with easily interpre ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  5. Dynamic virtual moulage based on thin film adhesive displays

    SBC: ARCHIE MD INC.            Topic: DHA17A002

    Providing Army combat medics with meaningful experience in treatment of battlefield injuries is a particular challenge. Moulage has the potential to assist in acquiring what could otherwise be very hard-to-come-by preparatory experience for distressing real-life emergencies medics and soldiers may encounter in the field. However, current approaches to moulage are limited in their ability to reflec ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  6. DEVELOPMENT OF A LOW-POWER, WIRELESS, WEARABLE MULTIPARAMETER MONITOR CAPABLE OF PULSE OXIMETRY AND OTHER VITAL SIGN MONITORING FROM THE CHEST, ARMS AND LEGS.

    SBC: Nonin Medical, Inc.            Topic: A16053

    Wearable devices have grown to meet the demand for continuous, noninvasive vital signs monitoring in the military and civilian health care markets.These devices have largely excluded pulse oximetry because non-traditional sites, such as the chest, arm and legs, pose a challenge. We have previously demonstrated the ability to accurately monitor pulse oximetry on the chest, arms and calf.This projec ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  7. Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration

    SBC: MAINSTREAM ENGINEERING CORP            Topic: DHP163003

    Warfighters in global regionsendemicto vector-borne diseases,such as malaria,experienceincreased probability of being non-combat casualties. Currently,amalariavaccineis under development that requirescryogenicstorageand transport (-150°C or lower)and therefore does not readily integrate with existingvaccine distribution networks such as the World Health Organization’s Expanded Program on Immuni ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  8. Development of a Specialized Miniature Stimulator System for Non-Opioid Pain Relief

    SBC: SPR THERAPEUTICS, INC.            Topic: NonDOD

    Successful completion of the previous Phase I study and additional clinical trials has demonstrated that percutaneous peripheral nerve stimulation (PNS) has the potential to provide non-opioid pain relief and improvements in function to injured Service members, Veterans, and civilians. Feedback from military advisors, clinicians, and patients have identified challenges that must be addressed to tr ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  9. Delivery System for Cryopreserved Eukaryotic Cell Vaccines

    SBC: SANARIA INC.            Topic: DHP163003

    A cryovial suitable for vaccine storage below -150 C, containing a septum to facilitate syringe preparation in the field does not exist, but is urgently needed for eukaryotic whole cell products. Sanaria PfSPZ Vaccine, consisting of radiation-attenuated whole Plasmodium falciparum sporozoites (PfSPZ), has protected >90% of recipients against malaria in 5 clinical trials in the US, Europe and Afric ...

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
  10. Field portable Coliform bacteria & E. Coli RNA biomarker LAMP- OSD system

    SBC: FABRICO TECHNOLOGY, INC.            Topic: DHA17004

    Fabrico Technology, Dr. Sanchita Bhadra and Professor Andrew Ellington of the University of Texas at Austin, have successfully demonstrated the proof-of-concept of an unparalleled, first-in-class in-field nucleic acid diagnostic platform for distinction of viable from non-viable E. coli and coliforms in

    SBIR Phase II 2018 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government